Abstract:Background: Osteosarcoma (OS) is the leading cancer-associated mortality in childhood and adolescence. Increasing evidence has demonstrated the key function of microRNAs (miRNAs) in OS development and chemoresistance. Among them, miRNA-605-3p acted as an important tumor suppressor and was frequently down-regulated in multiple cancers. However, the function of miR-650-3p in OS has not been reported. Objective: The aim of this work is to explore the novel role of miR-605-3p in osteosarcoma and its possible involvement in OS chemotherapy resistance. Method: The expression levels of miR-605-3p in OS tissues and cells were assessed by reverse transcription quantitative PCR (RT-qPCR). The relevance of miR-605-3p with the prognosis of OS patients was determined by the Kaplan-Meier analysis. Additionally, the influence of miR-605-3p on OS cell growth was analyzed using the cell counting kit-8, colony formation assay, and flow cytometry. The mRNA and protein expression of RAF1 were detected by RT-qPCR and western blot. The binding of miR-605-3p with the 3'-UTR of RAF1 was confirmed by dual-luciferase reporter assay. Results: Our results showed that miR-605-3p was markedly decreased in OS tissues and cells. A lower level of miR-605-3p was strongly correlated with lymph node metastasis and poor 5-year overall survival rate of OS patients. In vitro assay found that miR-605-3p suppressed OS cell proliferation and promoted cell apoptosis. Mechanistically, the proto-oncogene RAF1 was seen as a target of miR-605-3p and strongly suppressed by miR-605-3p in OS cells. Restoration of RAF1 markedly eliminated the inhibitory effect of miR-605-3p on OS progression, suggesting RAF1 as a key mediator of miR-605-3p. Consistent with the decreased level of RAF1, miR-605-3p suppressed the activation of both MEK and ERK in OS cells, which are the targets of RAF1. Moreover, lower levels of miR-605-3p were found in chemoresistant OS patients, and downregulated miR-605-3p increased the resistance of OS cells to therapeutic agents. Conclusion: Our data revealed that miR-605-3p serves as a tumor suppressor gene by regulating RAF1 and increasing the chemosensitivity of OS cells, which provided the novel working mechanism of miR-605-3p in OS. Engineering stable nanovesicles that could efficiently deliver miR-605-3p with therapeutic activity into tumors could be a promising therapeutic approach for the treatment of OS.

Mir-34c Inhibits Osteosarcoma Metastasis and Chemoresistance

MicroRNA-1236-3p Inhibits Human Osteosarcoma Growth

Mir-382 Inhibits Tumor Growth and Enhance Chemosensitivity in Osteosarcoma

MicroRNA-455-3p Inhibits Osteosarcoma Progression Via HSF1 Downregulation

595. Mir-199 Inhibits Tumor Growth and Enhance Chemosensitivity in Osteosarcoma

Mir-34c-3p Acts As A Tumor Suppressor Gene in Osteosarcoma by Targeting Marcks

miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1.

MiR-34a and Mir-203 Inhibit Survivin Expression to Control Cell Proliferation and Survival in Human Osteosarcoma Cells

Overexpression of Mir-664 is Associated with Enhanced Osteosarcoma Cell Migration and Invasion Ability Via Targeting SOX7

Mir-30 Inhibits the Progression of Osteosarcoma by Targeting MTA1.

Mir-3195 Suppresses the Malignant Progression of Osteosarcoma Cells Via Targeting SOX4.

MicroRNA-605-3p Inhibited the Growth and Chemoresistance of Osteosarcoma Cells via Negatively Modulating RAF1

Mir-216A Inhibits Osteosarcoma Cell Proliferation, Invasion and Metastasis by Targeting CDK14.

Mir-181D-5p-foxp1 Feedback Loop Modulates the Progression of Osteosarcoma.

Microrna Profiling Identifies Mir-195 Suppresses Osteosarcoma Cell Metastasis By Targeting Ccnd1

Mir-135B Stimulates Osteosarcoma Recurrence and Lung Metastasis Via Notch and Wnt/β-Catenin Signaling

Mir‐421 Promotes Apoptosis and Suppresses Metastasis of Osteosarcoma Cells Via Targeting LTBP2

MiR-199b-5p promotes malignant progression of osteosarcoma by regulating HER2.

Mir-495-3p Inhibits the Cell Proliferation, Invasion and Migration of Osteosarcoma by Targeting C1q/TNF-related Protein 3

MiR-134, Mediated by IRF1, Suppresses Tumorigenesis and Progression by Targeting VEGFA and MYCN in Osteosarcoma.

MicroRNA-876-5p Inhibits Cell Proliferation, Migration and Invasion by Targeting C-Met in Osteosarcoma.